Other candidates include anti-BDCA2 antibody litifilimab in phase 3 for SLE and phase 2 for cutaneous lupus erythematosus ... is that impacting the CD40L pathway, a central mechanism in immune ...

Cutaneous vasculitis (CV) is a term used for inflammation of the blood vessels in the skin that occurs in up to 70% of patients with lupus erythematosus (LE). The inflammation affects the smaller ...

standard therapy alone, according to data. ORLANDO — Twice-daily deucravacitinib 3 mg and 6 mg significantly improved cutaneous lupus erythematosus activity by week 16, according to a presenter ...

Considering taking supplements to treat cutaneous lupus erythematosus cle? Below is a list of common natural remedies used to treat or reduce the symptoms of cutaneous lupus erythematosus cle.

The foregoing results lead to the conclusion that patients with disseminated lupus erythematosus and some patients with rheumatoid arthritis present a delayed cutaneous hypersensitivity when ...

The present study used microbiome profiling to discover possible biomarkers and molecular pathways underlying ... Participant Systemic Lupus Erythematosus Disease Activity Index (SLEDAI) scores ...